Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 12:56 AM
NCT ID:
NCT05757167
Eligibility Criteria:
Inclusion Criteria:
* Aged between 16 years and 40 years (inclusive)
* Viable singleton pregnancy with gestational age estimated less than 13 6/7 weeks (inclusive) by ultrasound
* HIV-uninfected
* Willing to participate in the study schedule
* Planning to remain in the study area for the duration of pregnancy and 1 month after delivery
* Willing to deliver in a study-affiliated health facility
Exclusion Criteria:
* High risk pregnancy that requires referral for specialized care by local guidelines
* Active medical problem at the time of screening requiring higher level care
* Antimalarial receipt in the 2 weeks prior to screening
* Past allergy to Artemether or Lumefantrine or another condition that prohibits the receipt of either drug
* Current participation in another clinical research study
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
16 Years
Maximum Age:
40 Years
Study:
NCT05757167
Study Brief:
Protocol Section:
NCT05757167